Tag: JEAN KASEYA

Africa CDC Confirms Mpox Vaccine Production to Start in 2025

Michael Gwarisa

By Michael Gwarisa The Director-General of the Africa Centre for Disease Control (Africa CDC), Dr. Jean Kaseya, told a media briefing that local production of the Mpox vaccine on the continent will commence this year, although he did not provide specific timelines. In 2024, Africa CDC partnered with Bavarian Nordic to enhance vaccine manufacturing capabilities within Africa. The partnership aims to strengthen health security across the continent. We have the outcome; we have now started discussions with the successful bidders,” said Dr. Kaseya. “At the moment, we are finalizing some…

Read More

Zimbabwe Records 90 Days Without Mpox

Michael Gwarisa

By Michael Gwarisa Zimbabwe is among the few African countries that have not recorded any new Mpox cases in the past three months, a top official at the Africa Centres for Disease Control and Prevention (Africa CDC) has said. In October 2024, Zimbabwe reported its first cases of Mpox, two months after the Africa CDC declared Mpox a public health emergency of continental concern. However, recent data indicates that Zimbabwe has not recorded any confirmed cases during the past 90 days. Eight countries are now in the control phase, four…

Read More

#JUSTIN: Africa CDC Declares Mpox A Public Health Emergency of Continental Security

Michael Gwarisa

By Michael Gwarisa The Africa Centres for Disease Control and Prevention (Africa CDC) has officially declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017. This declaration, under Article 3, Paragraph F of the Africa CDC Statutes, empowers the organization to lead and coordinate responses to significant health emergencies. The statute mandates Africa CDC to “coordinate and support Member States in health emergency responses, particularly those declared PHECS or Public Health Emergency of International…

Read More